Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rocket Pharmaceuticals, Inc.

6.33
+0.18002.93%
Post-market: 6.400.0689+1.09%19:58 EDT
Volume:2.20M
Turnover:13.86M
Market Cap:674.97M
PE:-2.32
High:6.39
Open:6.13
Low:6.09
Close:6.15
Loading ...

Is Rocket Pharmaceuticals (NASDAQ:RCKT) In A Good Position To Deliver On Growth Plans?

Simply Wall St.
·
16 Apr

Rocket Pharmaceuticals CEO buys $101.6K in common stock

TIPRANKS
·
15 Apr

Rocket Pharmaceuticals (RCKT): Among Stocks Under $10 that Will Triple

Insider Monkey
·
09 Apr

Rocket Pharmaceuticals Price Target Maintained With a $42.00/Share by Needham

Dow Jones
·
09 Apr

We're Keeping An Eye On Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Rate

Simply Wall St.
·
02 Apr

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks
·
01 Apr

Rocket Pharmaceuticals Down Over 14%, on Track for Lowest Close Since September 2017 -- Data Talk

Dow Jones
·
01 Apr

Rocket Pharmaceuticals, Inc. (RCKT): A Bull Case Theory

Insider Monkey
·
05 Mar

Rocket Pharmaceuticals Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
03 Mar

Rocket Pharmaceuticals price target raised to $52 from $51 at Scotiabank

TIPRANKS
·
03 Mar

Rocket Pharmaceuticals Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
03 Mar

Bank of America Securities Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
02 Mar

When Will Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Turn A Profit?

Simply Wall St.
·
02 Mar

Analysts Are Bullish on Top Healthcare Stocks: BioRestorative Therapies (BRTX), Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
02 Mar

Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus

Zacks
·
01 Mar

Morgan Stanley Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
28 Feb

Rocket Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
28 Feb

Analysts Are Bullish on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT), Janux Therapeutics Inc (JANX)

TIPRANKS
·
28 Feb

Rocket Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Rocket Pharmaceuticals Q4 2024 GAAP EPS $(0.62) Beats $(0.71) Estimate

Benzinga
·
28 Feb